Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study

BACKGROUND: Diabetic patients on hemodialysis are at high risk of death from cardiovascular disease, and research has suggested that various biologic markers of inflammation, oxidative stress and hemostasis may give added value to clinical information for predicting cardiovascular event (CVE)-free s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayliss, George P., Weinrauch, Larry A., Gleason, Ray E., Lee, Annette T., D'Elia, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2013
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438364/
https://www.ncbi.nlm.nih.gov/pubmed/26069829
http://dx.doi.org/10.1093/ckj/sft116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438364/
https://www.ncbi.nlm.nih.gov/pubmed/26069829
http://dx.doi.org/10.1093/ckj/sft116

Ejemplares similares